Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 4Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 152Glioblastoma 147Glioma 94Neuroblastoma 50Medulloblastoma 33Central Nervous System Neoplasms 27Astrocytoma 27Neoplasms 24Ependymoma 23Sarcoma 22Carcinoma, Non-Small-Cell Lung 22Neurofibromatosis 1 20Melanoma 20Breast Neoplasms 20Rhabdomyosarcoma 18Osteosarcoma 18Sarcoma, Ewing 16Lung Neoplasms 16Gliosarcoma 16Rhabdoid Tumor 15Oligodendroglioma 15Wilms Tumor 13Meningioma 13Hepatoblastoma 13Diffuse Intrinsic Pontine Glioma 13Recurrence 12Neurofibroma, Plexiform 11Neoplasm Metastasis 11Meningeal Carcinomatosis 11Lymphoma, Non-Hodgkin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hearing Loss × CNS × Clear all
NCT07420751 2026-04-28

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Massachusetts General Hospital

Phase NA Active not recruiting
18 enrolled
CNS

Neurofibromatosis 2, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡